Applications of nanoparticle systems in drug delivery technology
Top Cited Papers
Open Access
- 1 January 2018
- journal article
- review article
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 26 (1) , 64-70
Abstract
The development of nanoparticle-based drug formulations has yielded the opportunities to address and treat challenging diseases. Nanoparticles vary in size but are generally ranging from 100 to 500 nm. Through the manipulation of size, surface characteristics and material used, the nanoparticles can be developed into smart systems, encasing therapeutic and imaging agents as well as bearing stealth property. Further, these systems can deliver drug to specific tissues and provide controlled release therapy. This targeted and sustained drug delivery decreases the drug related toxicity and increase patient's compliance with less frequent dosing. Nanotechnology has proven beneficial in the treatment of cancer, AIDS and many other disease, also providing advancement in diagnostic testing.Keywords
This publication has 104 references indexed in Scilit:
- Revolutionary Impact of Nanodrug Delivery on NeuroscienceCurrent Neuropharmacology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in ratsCancer Chemotherapy and Pharmacology, 2010
- Targeted Imaging and Therapy of Brain Cancer Using Theranostic NanoparticlesMolecular Pharmaceutics, 2010
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered ReleasePharmaceutical Research, 2010
- Stealth nanoparticles: High density but sheddable PEG is a key for tumor targetingJournal of Controlled Release, 2010
- Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS TherapeuticsJournal of Neuroimmune Pharmacology, 2010
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Carbon inhibits vascular endothelial growth factor‐ and fibroblast growth factor‐promoted angiogenesisFEBS Letters, 2007